FibroBiologics, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
FibroBiologics, Inc. (FBLG) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 831.00 thousand shares for the 1-month period ending 2025-03-31, per its 10-Q filed 2025-05-14.
Financial Statements › Shareholders' Equity › Shares Granted or Issued, Share-Based Payment Arrangement
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2025-05-14
- 2025-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 1 month 831.00K shares.
- 2024-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 1 month 758.74K shares.
- 2024-11-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 1 month 255.82K shares.
- 2024-10-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 1 month 25.00K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 1 month |
|---|---|
| 2025-03-31 | 831.00K shares 10-Q · filed 2025-05-14 |
| 2024-12-31 | 758.74K shares 10-Q · filed 2025-05-14 |
| 2024-11-30 | 255.82K shares 10-Q · filed 2025-05-14 |
| 2024-10-31 | 25.00K shares 10-Q · filed 2025-05-14 |
| 2024-08-31 | 25.00K shares 10-Q · filed 2025-05-14 |
| 2024-06-30 | 6.88K shares 10-Q · filed 2025-05-14 |
| 2024-03-31 | 216.88K shares 10-Q · filed 2025-05-14 |
| 2023-08-31 | 2.50K shares 10-Q · filed 2025-05-14 |
| 2023-02-28 | 3.69M shares 10-Q · filed 2025-05-14 |
| 2022-09-30 | 101.25K shares 10-Q · filed 2025-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 |